The DOI matches its Crossref record; 157 of the 161 references it cites were found in a registry or an index.
The role of microglia in amyloid clearance from the AD brain
Open accessAbstract
Alzheimer's disease (AD), the most prominent cause of senile dementia, is clinically characterized by the extracellular deposition of beta-amyloid (Abeta) and the intracellular neurofibrillary tangles. It has been well accepted that AD pathogenesis arises from perturbation in the homeostasis of Abeta in the brain. Abeta is normally produced at high levels in the brain and cleared in an equivalent rate. Thus, even a moderate decrease in the clearance leads to the accumulation of Abeta and subsequent amyloid deposition. Microglia are the tissue macrophages in the central nervous system (CNS) and have been shown to play major roles in internalization and degradation of Abeta. Abeta exists in the brain both in soluble and in fibrillar forms. Microglia interact with these two forms of Abeta in different ways. They take up soluble forms of Abeta through macropinocytosis and LDL receptor-related proteins (LRPs) mediated pathway. Fibrillar forms of Abeta interact with the cell surface innate immune receptor complex, initiating intracellular signaling cascades that stimulate phagocytosis. Inflammatory responses influence the activation status of microglia and subsequently regulate their ability to take up and degrade Abeta. ApoE and its receptors have been shown to play critical roles in these processes. In this review, we will explore the mechanisms that microglia utilize to clear Abeta and the effectors that modulate the processes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Evidence for a important role of microglial phagocytosis comes from studies that show that restricting microglial A uptake leads to increased cerebral A levels (El Khoury et al., 2007;Lee and Landreth, 2010).”
From PPARγ/RXRα-Induced and CD36-Mediated Microglial Amyloid-β Phagocytosis Results in Cognitive Improvement in Amyloid Precursor Protein/Presenilin 1 Mice (2012) · cites this paper as Lee and Landreth, 2010
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Microglial expression of receptors that promote the clearance and phagocytosis of A, such as CD36, TLR4, and TLR6 (Lee and Landreth, 2010), are mandatory for restricting amyloid plaque formation.”
From PPARγ/RXRα-Induced and CD36-Mediated Microglial Amyloid-β Phagocytosis Results in Cognitive Improvement in Amyloid Precursor Protein/Presenilin 1 Mice (2012) · cites this paper as Lee and Landreth, 2010
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Thus, microglia interacts with A through a recently characterized cell-surface receptor complex comprising CD36, ␣61 integrin, and CD47 (Lee and Landreth, 2010).”
From PPARγ/RXRα-Induced and CD36-Mediated Microglial Amyloid-β Phagocytosis Results in Cognitive Improvement in Amyloid Precursor Protein/Presenilin 1 Mice (2012) · cites this paper as Lee and Landreth, 2010
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“For example, they facilitate the clearance of Aβ through phagocytosis42, yet they can also exacerbate neurodegeneration by driving persistent neuroinflammation43.”
From Deletion of SPI1 in microglia exacerbates amyloid pathology by impairing microglial response in Alzheimer’s disease models (2026) · cites this paper as [42]
The cited source says what the claim attributes to it.
In the citing paper
“Microglia, the innate immune cells of the brain, dynamically interact with these disease processes to influence AD progression.”
From PLCG2 modulates TREM2 expression and signaling in response to Alzheimer's disease pathology (2025) · cites this paper as [5]
The cited source says what the claim attributes to it.
In the citing paper
“Because microglia are critical for A phagocytosis, the microglial presence at the A plaque can be interpreted as an attempt to clear this pathological deposit.”
From PPARγ/RXRα-Induced and CD36-Mediated Microglial Amyloid-β Phagocytosis Results in Cognitive Improvement in Amyloid Precursor Protein/Presenilin 1 Mice (2012) · cites this paper as Lee and Landreth, 2010
The cited source says what the claim attributes to it.
In the citing paper
“However, persisting neuroinflammation and sustained exposure to proinflammatory stimuli compromises microglial clearance functions as AD progresses (Lee and Landreth, 2010).”
From PPARγ/RXRα-Induced and CD36-Mediated Microglial Amyloid-β Phagocytosis Results in Cognitive Improvement in Amyloid Precursor Protein/Presenilin 1 Mice (2012) · cites this paper as Lee and Landreth, 2010
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Amyloid Hypothesis of Alzheimer’s Disease: Progress and Problems on the Road to Therapeutics
Hardy, J., & Selkoe, D. J. (2002) · Science · doi:10.1126/science.1072994 · Cited by 13,864
Corder, E. H., Saunders, A. M., Strittmatter, W. J., Schmechel, D. E., Gaskell, P. C., Small, G. W., Roses, A. D., Haines, J. L., & Pericak-Vance, M. A. (1993) · Science · doi:10.1126/science.8346443 · Cited by 9,429
Alzheimer's disease: the amyloid cascade hypothesis
Hardy, J. A., & Higgins, G. A. (1992) · Science · doi:10.1126/science.1566067 · Cited by 7,484
Resting microglial cells are highly dynamic surveillants of brain parenchyma in vivo
Nimmerjahn, A., Kirchhoff, F., & Helmchen, F. (2005) · Science · doi:10.1126/science.1110647 · Cited by 5,827
Goate, A., Chartier-Harlin, M.-C., Mullan, M., Brown, J., Crawford, F., Fidani, L., Giuffra, L., Haynes, A., Irving, N., James, L., et al. (1991) · Nature · doi:10.1038/349704a0 · Cited by 4,659
Microglia-mediated neurotoxicity: uncovering the molecular mechanisms
Block, M. L., Zecca, L., & Hong, J.-S. (2007) · Nature Reviews Neuroscience · doi:10.1038/nrn2038 · Cited by 4,110
Immunization with amyloid-β attenuates Alzheimer-disease-like pathology in the PDAPP mouse
Schenk, D., Barbour, R., Dunn, W., Gordon, G., Grajeda, H., Guido, T., Hu, K., Huang, J., Johnson-Wood, K., Khan, K., et al. (1999) · Nature · doi:10.1038/22124 · Cited by 3,160
A genome-wide association study identifies novel risk loci for type 2 diabetes
Sladek, R., Rocheleau, G., Rung, J., Dina, C., Shen, L., Serre, D., Boutin, P., Vincent, D., Belisle, A., Hadjadj, S., et al. (2007) · Nature · doi:10.1038/nature05616 · Cited by 2,993
Alzheimer-type neuropathology in transgenic mice overexpressing V717F β-amyloid precursor protein
Games, D., Adams, D., Alessandrini, R., Barbour, R., Borthelette, P., Blackwell, C., Carr, T., Clemens, J., Donaldson, T., Gillespie, F., et al. (1995) · Nature · doi:10.1038/373523a0 · Cited by 2,516
Heterogeneity in the distribution and morphology of microglia in the normal adult mouse brain
Lawson, L. J., Perry, V. H., Dri, P., & Gordon, S. (1990) · Neuroscience · doi:10.1016/0306-4522(90)90229-w · Cited by 2,045
Flagged first, then by citations
4 of the 161 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
Items 201–300 of 701
Microglial response to aging and neuroinflammation in the development of neurodegenerative diseases
Han, T., Xu, Y., Sun, L., Hashimoto, M., & Wei, J. (2023) · Neural Regeneration Research · doi:10.4103/1673-5374.385845 · Cited by 64
Wang, Z., Liu, J., Han, J., Zhang, T., Li, S., Hou, Y., Su, H., Han, F., & Zhang, C. (2024) · Journal of Neuroinflammation · doi:10.1186/s12974-024-03166-9 · Cited by 60
Reviewing reasons for the decreased CSF Abeta42 concentration in Alzheimer
Petra, E. S. (2012) · Frontiers in bioscience · doi:10.2741/4035 · Cited by 68
Distribution of microglia in the postnatal murine nigrostriatal system
Sharaf, A., Krieglstein, K., & Spittau, B. (2013) · Cell and Tissue Research · doi:10.1007/s00441-012-1537-y · Cited by 59
Innate sensing of mechanical properties of brain tissue by microglia
Ayata, P., & Schaefer, A. (2020) · Current Opinion in Immunology · doi:10.1016/j.coi.2020.01.003 · Cited by 57
Won, J., Kim, J., Annamalai, B., Shunmugavel, A., Singh, I., & Singh, A. K. (2013) · Journal of Alzheimer s Disease · doi:10.3233/jad-121786 · Cited by 60
Larochelle, A., Bellavance, M., Michaud, J.-P., & Rivest, S. (2015) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2015.09.017 · Cited by 60
Campos-Peña, V., Toral-Rios, D., Becerril-Pérez, F., Sánchez-Torres, C., Delgado-Namorado, Y., Torres-Ossorio, E., Franco-Bocanegra, D., & Carvajal, K. (2017) · Antioxidants & Redox Signaling · doi:10.1089/ars.2016.6768 · Cited by 58
Appleton, J., Finn, Q., Zanotti-Fregonara, P., Yu, M., Faridar, A., Nakawah, M. O., Zarate, C., Carrillo, M. C., Dickerson, B. C., Rabinovici, G. D., et al. (2025) · Brain · doi:10.1093/brain/awae234 · Cited by 58
P2Y6 Receptor-Mediated Microglial Phagocytosis in Radiation-Induced Brain Injury
Xu, Y., Hu, W., Liu, Y., Xu, P., Li, Z., Wu, R., Shi, X., & Tang, Y. (2015) · Molecular Neurobiology · doi:10.1007/s12035-015-9282-3 · Cited by 61
Apolipoprotein E isoform‐dependent microglia migration
Cudaback, E., Li, X., Montine, K. S., Montine, T. J., & Keene, C. D. (2011) · The FASEB Journal · doi:10.1096/fj.10-176891 · Cited by 58
The chemokine CXCL12 mediates the anti-amyloidogenic action of painless human nerve growth factor
Capsoni, S., Malerba, F., Carucci, N. M., Rizzi, C., Criscuolo, C., Origlia, N., Calvello, M., Viegi, A., Meli, G., & Cattaneo, A. (2016) · Brain · doi:10.1093/brain/aww271 · Cited by 58
Role of Mesenchymal Stem Cells in Counteracting Oxidative Stress—Related Neurodegeneration
Angeloni, C., Gatti, M., Prata, C., Hrelia, S., & Maraldi, T. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21093299 · Cited by 62
Interleukin-4 affects microglial autophagic flux
Tang, R.-H., Qi, R.-Q., & Liu, H.-Y. (2019) · Neural Regeneration Research · doi:10.4103/1673-5374.255975 · Cited by 59
Dual dose-dependent effects of fingolimod in a mouse model of Alzheimer’s disease
Carreras, I., Aytan, N., Choi, J., Tognoni, C. M., Kowall, N. W., Jenkins, B. G., & Dedeoglu, A. (2019) · Scientific Reports · doi:10.1038/s41598-019-47287-1 · Cited by 57
Validation of Induced Microglia-Like Cells (iMG Cells) for Future Studies of Brain Diseases
Banerjee, A., Lu, Y., Do, K., Mize, T. J., Wu, X., Chen, X., & Chen, J. (2021) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2021.629279 · Cited by 57
Microglial Extracellular Vesicles as Vehicles for Neurodegeneration Spreading
Aires, I. D., Ribeiro‐Rodrigues, T., Boia, R., Ferreira-Rodrigues, M., Girão, H., Ambrósio, A. F., & Santiago, A. R. (2021) · Biomolecules · doi:10.3390/biom11060770 · Cited by 57
Modulation of Neuroinflammation in the Central Nervous System: Role of Chemokines and Sphingolipids
Gualtierotti, R., Guarnaccia, L., Beretta, M., Navone, S. E., Campanella, R., Riboni, L., Rampini, P. M., & Marfia, G. (2017) · Advances in Therapy · doi:10.1007/s12325-016-0474-7 · Cited by 58
INPP5D deficiency attenuates amyloid pathology in a mouse model of Alzheimer's disease
Lin, P. B., Tsai, A. P., Soni, D., Lee‐Gosselin, A., Moutinho, M., Puntambekar, S. S., Landreth, G. E., Lamb, B. T., & Oblak, A. L. (2023) · Alzheimer's & Dementia · doi:10.1002/alz.12849 · Cited by 54
Self-citationGupta, A., Lacoste, B., Pistell, P. J., Ingram, D. K., Hamel, É., Alaoui‐Jamali, M. A., Szarek, W. A., Vlahakis, J. Z., Su, J., Song, W., et al. (2014) · Journal of Neurochemistry · doi:10.1111/jnc.12927 · Cited by 52
In Vivo Chimeric Alzheimer’s Disease Modeling of Apolipoprotein E4 Toxicity in Human Neurons
Najm, R., Zalocusky, K. A., Zilberter, M., Yoon, S. Y., Hao, Y., Koutsodendris, N., Nelson, M., Rao, A., Taubes, A., Jones, E. A., et al. (2020) · Cell Reports · doi:10.1016/j.celrep.2020.107962 · Cited by 52
Microglial activation as a hallmark of neuroinflammation in Alzheimer’s disease
Ebrahimi, R., Nejad, S. S., Tafti, M. F., Karimi, Z., Sadr, S. R., Hussein, D. R., Talebian, N., & Esmaeilpour, K. (2025) · Metabolic Brain Disease · doi:10.1007/s11011-025-01631-9 · Cited by 58
Iron potentiates microglial interleukin‐1β secretion induced by amyloid‐β
Nnah, I. C., Lee, C., & Wessling‐Resnick, M. (2019) · Journal of Neurochemistry · doi:10.1111/jnc.14906 · Cited by 54
Self-citationLi, Y., Cheng, D., Cheng, R., Zhu, X., Wan, T., Liu, J., & Zhang, R. (2014) · PLoS ONE · doi:10.1371/journal.pone.0099939 · Cited by 51
Alzheimer disease: modeling an Aβ-centered biological network
Campion, D., Pottier, C. P., Nicolas, G., Guennec, K. L., & Rovelet‐Lecrux, A. (2016) · Molecular Psychiatry · doi:10.1038/mp.2016.38 · Cited by 55
Synergistic Actions of Microglia and Astrocytes in the Progression of Alzheimer's Disease
Bouvier, D. S., & Murai, K. K. (2015) · Journal of Alzheimer s Disease · doi:10.3233/jad-143156 · Cited by 52
Humpel, C. (2015) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2015.00047 · Cited by 53
Varma, V. R., Desai, R. J., Navakkode, S., Wong, L., Anerillas, C., Loeffler, T., Schilcher, I., Mahesri, M., Chin, K., Horton, D. B., et al. (2022) · Molecular Psychiatry · doi:10.1038/s41380-022-01912-0 · Cited by 51
Canepa, E., Parodi‐Rullán, R. M., Vázquez‐Torres, R., Gamallo‐Lana, B., Guzman‐Hernandez, R. A., Lemon, N. L., Angiulli, F., Debure, L., Ilies, M. A., Østergaard, L., et al. (2023) · Alzheimer s & Dementia · doi:10.1002/alz.13063 · Cited by 54
Understanding the function of ABCA7 in Alzheimer's disease
Li, H., Karl, T., & Garner, B. (2015) · Biochemical Society Transactions · doi:10.1042/bst20150105 · Cited by 52
Lull, M. E., Levesque, S., Surace, M. J., & Block, M. L. (2011) · PLoS ONE · doi:10.1371/journal.pone.0020153 · Cited by 53
Apolipoprotein E Isoform-Specific Effects on Lipoprotein Receptor Processing
Bachmeier, C. J., Shackleton, B., Ojo, J. O., Paris, D., MULLAN, M. J., & Crawford, F. (2014) · NeuroMolecular Medicine · doi:10.1007/s12017-014-8318-6 · Cited by 50
Research progress on the NLRP3 inflammasome and its role in the central nervous system
Liu, S., Mi, W., & Wang, Y. (2013) · Neuroscience Bulletin · doi:10.1007/s12264-013-1328-9 · Cited by 51
Brain Inflammation Connects Cognitive and Non-Cognitive Symptoms in Alzheimer’s Disease
Sellés, M. C., Oliveira, M. M., & Ferreira, S. T. (2018) · Journal of Alzheimer s Disease · doi:10.3233/jad-179925 · Cited by 51
Bai, Y., Chen, L., Chen, Y., Chen, X., Dong, Y., Zheng, S., Zhang, L., Li, W., Du, J., & Li, H. (2019) · RSC Advances · doi:10.1039/c9ra08245j · Cited by 51
Ramirez, A., van der Flier, W. M., Herold, C., Ramonet, D., Heilmann, S., Lewczuk, P., Popp, J., Lacour, A., Drichel, D., Louwersheimer, E., et al. (2014) · Human Molecular Genetics · doi:10.1093/hmg/ddu372 · Cited by 49
Rohn, T. T. (2013) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2013/860959 · Cited by 51
Cysteinyl leukotriene receptor 1 mediates LTD4-induced activation of mouse microglial cells in vitro
Yu, S.-Y., Zhang, X.-Y., Wang, X., Xu, D., Chen, L., Zhang, L., Fang, S., Lu, Y., Zhang, W., & Wei, E. (2013) · Acta Pharmacologica Sinica · doi:10.1038/aps.2013.130 · Cited by 49
Kokiko-Cochran, O., Ransohoff, L., Veenstra, M., Lee, S., Saber, M., Sikora, M., Teknipp, R., Xu, G., Bemiller, S., Wilson, G., et al. (2016) · Journal of Neurotrauma · doi:10.1089/neu.2015.3970 · Cited by 49
IL-4 and IL-10 promotes phagocytic activity of microglia by up-regulation of TREM2
Yi, S., Jiang, X., Tang, X., Li, Y., Xiao, C., Zhang, J., & Zhou, T. (2020) · Cytotechnology · doi:10.1007/s10616-020-00409-4 · Cited by 49
Pal, A., Rani, I., Pawar, A. T., Picozza, M., Rongioletti, M. C. A., & Squitti, R. (2021) · Biomolecules · doi:10.3390/biom11111598 · Cited by 48
Ullah, R., & Lee, E. J. (2023) · Experimental Neurobiology · doi:10.5607/en23014 · Cited by 51
Nguyen, T. T. N., Kim, Y. M., Kim, T. D., Le, O. T. T., Kim, J. J., Kang, H. C., Hasegawa, H., Kanaho, Y., Jou, I., & Lee, S. Y. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.410126 · Cited by 49
Intracerebral haemorrhage in Down syndrome: protected or predisposed?
Buss, L., Fisher, E., Hardy, J., Nižetić, D., Groet, J., Pulford, L. J., & Strydom, A. (2016) · F1000Research · doi:10.12688/f1000research.7819.1 · Cited by 48
Yokokawa, K., Iwahara, N., Hisahara, S., Emoto, M. C., Saito, T., Suzuki, H., Manabe, T., Matsumura, A., Matsushita, T., Suzuki, S., et al. (2019) · Journal of Alzheimer s Disease · doi:10.3233/jad-190817 · Cited by 48
Zhang, L., Xu, J., Gao, J., Wu, Y., Yin, M., & Zhao, W. (2018) · Reviews in the Neurosciences · doi:10.1515/revneuro-2017-0084 · Cited by 51
PHF-Core Tau as the Potential Initiating Event for Tau Pathology in Alzheimer’s Disease
Luna‐Viramontes, N. I., Campa-Córdoba, B. B., Ontiveros‐Torres, M. Á., Harrington, C. R., Villanueva‐Fierro, I., Guadarrama-Ortíz, P., Garcés‐Ramírez, L., de la Cruz, F., Hernándes‐Alejandro, M., Martínez-Robles, S., et al. (2020) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2020.00247 · Cited by 47
Matsumoto, K., Chiba, Y., Fujihara, R., Kubo, H., Sakamoto, H., & Ueno, M. (2015) · Histochemistry and Cell Biology · doi:10.1007/s00418-015-1366-7 · Cited by 46
Calcium Signaling Deficits in Glia and Autophagic Pathways Contributing to Neurodegenerative Disease
Mustaly-Kalimi, S., Littlefield, A. M., & Stutzmann, G. E. (2018) · Antioxidants and Redox Signaling · doi:10.1089/ars.2017.7266 · Cited by 47
Transcriptional Networks of Microglia in Alzheimer’s Disease and Insights into Pathogenesis
Chew, G., & Petretto, E. G. (2019) · Genes · doi:10.3390/genes10100798 · Cited by 46
Genetic Dissection of Alzheimer’s Disease Using Drosophila Models
Jeon, Y., Lee, J., Choi, B., Won, S.-Y., & Cho, K. S. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21030884 · Cited by 46
Ren, X., Yao, L., Wang, Y., Mei, L., & Xiong, W.-C. (2022) · Journal of Neuroinflammation · doi:10.1186/s12974-022-02422-0 · Cited by 42
Tubby regulates microglial phagocytosis through MerTK
Caberoy, N. B., Alvarado, G., & Li, W. (2012) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2012.07.009 · Cited by 47
Blume, T., Focke, C., Peters, F., Deußing, M., Albert, N. L., Lindner, S., Gildehaus, F., von Ungern‐Sternberg, B., Ozmen, L., Baumann, K., et al. (2018) · Journal of Neuroinflammation · doi:10.1186/s12974-018-1347-6 · Cited by 45
Zavatti, M., Gatti, M., Beretti, F., Palumbo, C., & Maraldi, T. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23094967 · Cited by 48
Borsom, E. M., Conn, K. A., Keefe, C. R., Herman, C., Orsini, G. M., Hirsch, A. H., Avila, M. P., Testo, G., Jaramillo, S. A., Bolyen, E. K., et al. (2023) · Microbiology Spectrum · doi:10.1128/spectrum.03458-22 · Cited by 45
Kok, F. K., van Leerdam, S., & de Lange, E. C. M. (2022) · Journal of Alzheimer s Disease · doi:10.3233/jad-210607 · Cited by 46
Amandine, E. B., & Marchalant, Y. (2015) · Aging and Disease · doi:10.14336/ad.2015.0617 · Cited by 43
Amyloidosis in Retinal Neurodegenerative Diseases
Masuzzo, A., Dinet, V., Cavanagh, C., Mascarelli, F., & Krantic, S. M. (2016) · Frontiers in Neurology · doi:10.3389/fneur.2016.00127 · Cited by 45
Ahmad, S., Bannister, C. A., van der Lee, S. J., Vojinović, D., Adams, H. H. H., Ramírez, A., Escott‐Price, V., Sims, R., Baker, E. A., Williams, J. H., et al. (2018) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2018.01.005 · Cited by 46
β-amyloid and Oxidative Stress: Perspectives in Drug Development
Caruso, G., Spampinato, S. F., Cardaci, V., Caraci, F., Sortino, M. A., & Merlo, S. (2019) · Current Pharmaceutical Design · doi:10.2174/1381612825666191209115431 · Cited by 45
α-Linolenic acid induces clearance of Tau seeds via Actin-remodeling in Microglia
Desale, S. E., & Chinnathambi, S. (2021) · Molecular Biomedicine · doi:10.1186/s43556-021-00028-1 · Cited by 43
Zhao, P., Xu, Y., Fan, X., Li, L., Li, X., Arase, H., Tong, Q., Zhang, N., & An, Z. (2022) · mAbs · doi:10.1080/19420862.2022.2107971 · Cited by 46
Activated Scavenger Receptor A Promotes Glial Internalization of Aβ
Zhang, H., Su, Y., Zhou, W.-W., Wang, S.-W., Xu, P., Yu, X., & Liu, R. (2014) · PLoS ONE · doi:10.1371/journal.pone.0094197 · Cited by 43
Lee, A. Y., Lee, M. H., Lee, S., & Cho, E. J. (2018) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.8b00836 · Cited by 43
Mehrabadi, S., Motevaseli, E., Sadr, S. S., & Moradbeygi, K. (2019) · Behavioural Brain Research · doi:10.1016/j.bbr.2019.112362 · Cited by 43
Neuroinflammation in Alzheimer's disease and beneficial action of luteolin
Delgado, A., Cholevas, C., & Theoharides, T. C. (2021) · BioFactors · doi:10.1002/biof.1714 · Cited by 48
Roltsch, E. A., Holcomb, L. A., Young, K. A., Marks, A., & Zimmer, D. B. (2010) · Journal of Neuroinflammation · doi:10.1186/1742-2094-7-78 · Cited by 44
Therapeutic insights elaborating the potential of retinoids in Alzheimer’s disease
Behl, T., Kaur, D., Sehgal, A., Singla, R. K., Makeen, H. A., Albratty, M., Alhazmi, H. A., Meraya, A. M., & BUNGAU, S. G. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.976799 · Cited by 43
The therapeutic potential of bone marrow‐derived macrophages in neurological diseases
Zhou, K., Han, J., Wang, Y., Xu, Y., Zhang, Y., & Zhu, C. (2022) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.13964 · Cited by 44
Cattaneo, A., & Capsoni, S. (2018) · Pharmacological Research · doi:10.1016/j.phrs.2018.10.028 · Cited by 42
NLRP3 and Infections: β-Amyloid in Inflammasome beyond Neurodegeneration
Sita, G., Graziosi, A., Hrelia, P., & Morroni, F. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22136984 · Cited by 43
Research progress on interleukin-33 and its roles in the central nervous system
Han, P., Mi, W., & Wang, Y.-Q. (2011) · Neuroscience Bulletin · doi:10.1007/s12264-011-1025-5 · Cited by 41
Hunter, S., Arendt, T., & Brayne, C. (2013) · Molecular Neurobiology · doi:10.1007/s12035-013-8445-3 · Cited by 41
Validating GWAS Variants from Microglial Genes Implicated in Alzheimer’s Disease
dos Santos, L. R., Pimassoni, L. H. S., Sena, G. G. S., Camporez, D., Belcavello, L., Trancozo, M., Morelato, R. L., Errera, F. I. V., Passos‐Bueno, M. R., & Paula, F. (2017) · Journal of Molecular Neuroscience · doi:10.1007/s12031-017-0928-7 · Cited by 42
The role of TREM2 in Alzheimer's disease; evidence from transgenic mouse models
Karanfilian, L., Tosto, M. G., & Malki, K. (2019) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2019.09.004 · Cited by 40
Koppel, K., Tang, H., Javed, I., Parsa, M. R., Mortimer, M., Davis, T. P., Lin, S., Chaffee, A. L., Ding, F., & Ke, P. C. (2020) · Nanoscale · doi:10.1039/d0nr02710c · Cited by 41
Tajbakhsh, A., Read, M. I., Barreto, G. E., Ávila-Rodriguez, M., Hayat, S. M. G., & Sahebkar, A. (2021) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2021.173873 · Cited by 41
Kim, S., Sharma, C., Jung, U. J., & Kim, S. R. (2023) · Biomedicines · doi:10.3390/biomedicines11051383 · Cited by 40
Therapeutic effects of phlorotannins in the treatment of neurodegenerative disorders
Kwon, S. Y., Kwon, O. I., Hwang, H. J., Shin, H., & Yang, S. (2023) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2023.1193590 · Cited by 43
Laval, K., & Enquist, L. W. (2021) · Frontiers in Neurology · doi:10.3389/fneur.2021.658695 · Cited by 43
Takata, K., Ginhoux, F., & Shimohama, S. (2021) · Biochemical Pharmacology · doi:10.1016/j.bcp.2021.114754 · Cited by 40
Ko, C., Chu, Y., Narumiya, S., Chi, J.-Y., Furuyashiki, T., Aoki, T., Wang, S., Chang, W., & Wang, J. (2014) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2014.11.020 · Cited by 40
Yang, S., Magnutzki, A., Alami, N. O., Lattke, M., Hein, T. M., Scheller, J. S., Kröger, C., Oswald, F., Yilmazer‐Hanke, D., Wirth, T., et al. (2021) · Cells · doi:10.3390/cells10102669 · Cited by 42
Therapeutic Potential of Different Natural Products for the Treatment of Alzheimer’s Disease
Chakraborty, B., Mukerjee, N., Maitra, S., Zehravi, M., Mukherjee, D., Ghosh, A., Massoud, E. E. S., & Rahman, M. H. (2022) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2022/6873874 · Cited by 42
Glucocorticoid programming of neuroimmune function
Walker, D. J., & Spencer, K. A. (2017) · General and Comparative Endocrinology · doi:10.1016/j.ygcen.2017.07.016 · Cited by 42
Gauthier, S. G., Zhang, H., Ng, K. P., Pascoal, T. A., & Rosa‐Neto, P. (2018) · Translational Neurodegeneration · doi:10.1186/s40035-018-0117-9 · Cited by 42
Heme and hemoglobin suppress amyloid β–mediated inflammatory activation of mouse astrocytes
Sankar, S. B., Donegan, R. K., Shah, K. J., Reddi, A. R., & Wood, L. B. (2018) · Journal of Biological Chemistry · doi:10.1074/jbc.ra117.001050 · Cited by 41
Nazareth, L., John, J. A. S., Murtaza, M., & Ekberg, J. A. K. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.660259 · Cited by 42
Surface‐Modified Protein Microspheres Capture Amyloid‐β and Inhibit its Aggregation and Toxicity
Richman, M., Wilk, S., Skirtenko, N., Perelman, A., & Rahimipour, S. (2011) · Chemistry - A European Journal · doi:10.1002/chem.201101326 · Cited by 39
Protein Clearance Mechanisms of Alpha-Synuclein and Amyloid-Beta in Lewy Body Disorders
Deleidi, M., & Maetzler, W. (2012) · International Journal of Alzheimer s Disease · doi:10.1155/2012/391438 · Cited by 40
Rao, A. T., Chen, N., Kim, M. J., Blumenfeld, J. R., Yip, O., Liang, Z., Shostak, D. M., Hao, Y., Nelson, M. R., Koutsodendris, N., et al. (2024) · Cell stem cell · doi:10.1016/j.stem.2024.10.005 · Cited by 48
URMC-099 facilitates amyloid-β clearance in a murine model of Alzheimer’s disease
Kiyota, T., Machhi, J., Lu, Y., Dyavarshetty, B., Nemati, M., Zhang, G., Mosley, R. L., Gelbard, H. A., & Gendelman, H. E. (2018) · Journal of Neuroinflammation · doi:10.1186/s12974-018-1172-y · Cited by 39
Caruso, G., Benatti, C., Musso, N., Fresta, C. G., Fidilio, A., Spampinato, G., Brunello, N., Bucolo, C., Drago, F., Lunte, S. M., et al. (2021) · Biomedicines · doi:10.3390/biomedicines9050477 · Cited by 40
Zhang, M., Qian, X., Hu, J., Zhang, Y., Lin, X., Hai, W., Shi, K., Jiang, X., Li, Y., Tang, H., et al. (2023) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-023-06446-3 · Cited by 38
Aging and the neurovascular unit
del Zoppo, G. J. (2012) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2012.06686.x · Cited by 35
Infliximab ameliorates AD-associated object recognition memory impairment
Kim, D. H., Choi, S., Jho, J., Park, M., Kang, J., Park, S. J., Ryu, J. H., Jo, J., Kim, H. H., & Kim, B. C. (2016) · Behavioural Brain Research · doi:10.1016/j.bbr.2016.06.001 · Cited by 37
Kajiwara, Y., McKenzie, A. T., Dorr, N. P., Sosa, M. A. G., Elder, G. A., Schmeidler, J., Dickstein, D. L., Bozdagi, O., Zhang, B., & Buxbaum, J. D. (2016) · Human Molecular Genetics · doi:10.1093/hmg/ddw265 · Cited by 39
Chuang, K., Li, M., Lin, N., Chang, C.-H., Lu, I.-H., Pan, I.-H., Takahashi, T., Perng, M., & Wen, S. (2017) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2017/5414297 · Cited by 40
Experimental alcoholism primes structural and functional impairment of the glymphatic pathway
Liu, Q., Yan, L., Huang, M., Zeng, H., Satyanarayanan, S. K., Shi, Z., Chen, D., Lu, J., Pei, Z., Yao, X., et al. (2019) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2019.06.029 · Cited by 38
Metadata
- Authors
- Lee, C. Y. D., & Landreth, G. E.
- Affiliations
- Case Western Reserve University (US)
- Corresponding author
- Landreth, Gary E.
- ORCID
- Landreth, Gary E.
- Venue
- Journal of Neural Transmission
- Published
- 2010-06-15
- Volume
- 117
- Issue
- 8
- Pages
- 949-960
- ISSN
- 0300-9564 (ISSN-L)
- 1435-1463
- PMC
- PMC3653296
- OpenAlex
- W2038594716
- Cited by
- 701
- References
- 161
- Citations by year
- 2026: 26 · 2025: 49 · 2024: 74 · 2023: 54 · 2022: 66 · 2021: 50 · 2020: 51 · 2019: 43 · 2018: 56 · 2017: 31 · 2016: 29 · 2015: 43 · 2014: 35 · 2013: 36 · 2012: 31
- FWCI
- 3.02
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Journal of Neural Transmission (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Institute on Aging (R01AG020202, R01AG030482, R01AG016740)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Keywords
- microglia, amyloid-beta clearance, Alzheimer's disease, amyloid deposition, macropinocytosis, LDL receptor-related protein, phagocytosis, innate immune receptors, inflammation, microglial activation, apolipoprotein E, amyloid clearance
- MeSH terms
- Alzheimer Disease, Amyloid, Apolipoproteins E, Brain, Humans, Inflammation, Microglia
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
